<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2025-6175</article-id><article-id custom-type="edn" pub-id-type="custom">LKJGTI</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-6175</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОГНОЗИРОВАНИЕ И ДИАГНОСТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROGNOSIS AND DIAGNOSTICS</subject></subj-group></article-categories><title-group><article-title>Индикаторы системного воспалительного ответа и их взаимосвязь с фибрилляцией предсердий у больных инфарктом миокарда с подъемом сегмента ST после чрескожного коронарного вмешательства</article-title><trans-title-group xml:lang="en"><trans-title>Parameters of the systemic inflammatory response and their relationship with atrial fibrillation in patients with ST-elevation myocardial infarction after percutaneous coronary intervention</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9250-557X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гельцер</surname><given-names>Б. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Geltser</surname><given-names>B. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Борис Израйльевич Гельцер — д.м.н., профессор, член­корр. РАН, Школа медицины и наук о жизни, зам. директора по научной работе</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Far Eastern Federal University. School of Medicine, Deputy Director for Research</p></bio><email xlink:type="simple">bboris.geltser@vvsu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4539-685X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шахгельдян</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shahgeldyan</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карина Иосифовна Шахгельдян — д.т.н., доцент, Школа медицины и наук о жизни, зав. лабораторией анализа больших данных в здравоохранении и медицине, директор Научно-­образовательного центра искусственного интеллекта</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">carina.shahgeldyan@vvsu.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-3745-5399</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пак</surname><given-names>Р. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Pak</surname><given-names>R. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Регина Леонидовна Пак — ассистент, Школа медицины и наук о жизни, м.н.с. лаборатории анализа больших данных в здравоохранении и медицине; Приморская краевая больница № 1, врач анестезиолог­-реаниматолог отделения реанимации и интенсивной терапии регионального сосудистого центра</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">regina@pak.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6722-2535</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Домжалов</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Domzhalov</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игорь Геннадьевич Домжалов — аспирант, Школа медицины и наук о жизни, младший научный сотрудник лаборатории анализа больших данных в здравоохранении и медицине; Приморская краевая больница № 1, врач анестезиолог­реаниматолог отделения реанимации и интенсивной терапии регионального сосудистого центра</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">igor@domzhalov.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8726-0491</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кокарев</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kokarev</surname><given-names>E. An.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгений Анатольевич Кокарев — к.м.н., зав. отделением реанимации и интенсивной терапии отделения реанимации и интенсивной терапии регионального сосудистого центра</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">Evgeniy@Kokarev.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5830-1322</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котельников</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotelnikov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Николаевич Котельников — д.м.н., профессор, Школа медицины, профессор департамента клинической медицины</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">671235@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет;&#13;
ФГБОУ ВО Владивостокский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University;&#13;
Vladivostok State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет; &#13;
ГБУЗ Приморская краевая клиническая больница № 1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University;&#13;
Primorsky Regional Clinical Hospital No. 1,</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБУЗ Приморская краевая клиническая больница № 1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Primorsky Regional Clinical Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>05</day><month>07</month><year>2025</year></pub-date><volume>30</volume><issue>5</issue><fpage>6175</fpage><lpage>6175</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гельцер Б.И., Шахгельдян К.И., Пак Р.Л., Домжалов И.Г., Кокарев Е.А., Котельников В.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Гельцер Б.И., Шахгельдян К.И., Пак Р.Л., Домжалов И.Г., Кокарев Е.А., Котельников В.Н.</copyright-holder><copyright-holder xml:lang="en">Geltser B.I., Shahgeldyan K.I., Pak R.L., Domzhalov I.G., Kokarev E.A., Kotelnikov V.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/6175">https://russjcardiol.elpub.ru/jour/article/view/6175</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценка предиктивного потенциала индикаторов воспалительного ответа (ИВО) для стратификации риска впервые резвившейся фибрилляции предсердий (ФП) у больных инфарктом миокарда с подъемом сегмента ST (ИМпST) после чрескожного коронарного вмешательства (ЧКВ).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Анализировали данные 4152 электронных историй болезни пациентов с ИМпST (2858 мужчин и 1294 женщин).  Выделено 2 группы: первая - 3781 (91,1%) больной без нарушения сердечного ритма (СР), вторая -  371 (8,9%) - с впервые зарегистрированной ФП после ЧКВ (ПоФП). Состояние коронарного кровотока после ЧКВ оценивали по шкале The thrombolysis in myocardial infarction (TIMI). Рассчитывали ИВО, разработанные ранее (NLR, PLR, MLR, SII, SIRI, AISI), и новые индексы: NER (отношение нейтрофилов к эозинофилам) и NBR (отношение нейтрофилов к базофилам).</p></sec><sec><title>Результаты</title><p>Результаты. Оценка ИВО у больных ИМпST с ФП и без нарушений СР после ЧКВ с различным уровнем TIMI свидетельствовала о более выраженных изменениях этих показателей при сочетании признаков ПоФП и TIMI &lt;3.  Наибольший предиктивный потенциал в отношении ПоФП имели нейтрофилы &gt;75% (ОШ-2,57; AUC-0,779), NLR &gt;6,29 (ОШ-2,61; АUC-0,757), эозинофилы &lt;0,21% (ОШ- 2,74; AUC- 0,739), AISI (ОШ- 2,14; AUC- 0,737), NBR (ОШ-2,29; AUC-0,727) и NER (ОШ-2,49; AUC-0,725). Меньший прогностический ресурс был у показателей MLR и PLR.</p></sec><sec><title>Заключение</title><p>Заключение. У больных ИМпST с ПоФП интенсивность системного воспалительного ответа существенно выше, чем у лиц без нарушения СР. Прогностический потенциал новых индикаторов NER и NBR был сопоставим с классическими ИВО: NLR, SII, SIRI, AISI.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To assess the predictive potential of inflammatory response indicators for risk stratification of new­onset atrial fibrillation (AF) in patients with ST­elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI).</p></sec><sec><title>Material and methods</title><p>Material and methods. We analyzed data from 4152 electronic health records of patients with STEMI (2858 men and 1294 women). Two following groups were identified: the first group included 3781 (91,1%) patients without cardiac arrhythmia (CA), while the second group included 371 (8,9%) patients with newonset AF after PCI (POAF). The state of coronary flow after PCI was assessed using the thrombolysis in myocardial infarction (TIMI) score. Previously developed (neutrophil/lymphocyte (NLR), platelet/lymphocyte (PLR), monocyte/lymphocyte (MLR), systemic immune inflammation index (SII), systemic inflammatory response index (SIRI) and systemic inflammation total index (AISI)) and novel inflammatory response indicators (neutrophil/eosinophil ratio (NER) and neutrophil/basophil ratio (NBR)) were calculated.</p></sec><sec><title>Results</title><p>Results. In patients with STEMI with AF and without CAs after PCI with different TIMI levels indicated more pronounced inflammatory response changes with a combination of POAF and TIMI &lt;3. The highest predictive potential for POAF was demonstrated by neutrophil rate &gt;75% (odds ratio (OR)=2,57; AUC=0,779), NLR &gt;6,29 (OR=2,61; AUC=0,757), eosinophil rate &lt;0,21% (OR=2,74; AUC=0,739), AISI (OR=2,14; AUC=0,737), NBR (OR=2,29; AUC=0,727) and NER (OR=2,49; AUC=0,725). MLR and PLR had lower predictive power.</p></sec><sec><title>Conclusion</title><p>Conclusion. In patients with STEMI and POAF, the intensity of the systemic inflammatory response is significantly higher than in individuals without CAs. The prognostic potential of the novel inflammatory response indicators (NER and NBR) was comparable to the classical ones (NLR, SII, SIRI, AISI).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>индикаторы системного воспалительного ответа</kwd><kwd>инфаркт миокарда с подъемом сегмента ST</kwd><kwd>фибрилляция предсердий</kwd><kwd>чрескожное коронарное вмешательство</kwd></kwd-group><kwd-group xml:lang="en"><kwd>systemic inflammatory response indicators</kwd><kwd>ST­-segment elevation myocardial infarction</kwd><kwd>atrial fibrillation</kwd><kwd>percutaneous coronary intervention</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Государственное задание FZNS-2023-0010.</funding-statement><funding-statement xml:lang="en">State assignment FZNS-2023-0010.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Зыков М. В., Барбараш О. Л. Патогенетические и клинические аспекты фибрилляции предсердий при инфаркте миокарда. Российский кардиологический журнал. 2021;26(2). doi:10.15829/1560-4071-2021-43073.</mixed-citation><mixed-citation xml:lang="en">Zykov MV, Barbarash OL. Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction. Russ J of Cardiol. 2021;26(2):4307. (In Russ.) doi:10.15829/1560-4071-2021-43073.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Pacheco H, Marquez MF, Arias-Mendoza A, et al. Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. J Cardiol. 2015;66:148-54. doi:10.1016/j.jjcc.2014.11.001.</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Pacheco H, Marquez MF, Arias-Mendoza A, et al. Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. J Cardiol. 2015;66:148-54. doi:10.1016/j.jjcc.2014.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Laxmi Narayan Goit, Shaning Yang. Slow Blood Flow after Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction, Unstable Angina and Coronary Total Occlusion. Global Journal of Life Sciences. 2021;2(1): 37-44. doi:10.46633/gjls.020105</mixed-citation><mixed-citation xml:lang="en">Laxmi Narayan Goit, Shaning Yang. Slow Blood Flow after Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction, Unstable Angina and Coronary Total Occlusion. Global Journal of Life Sciences. 2021;2(1): 37-44. doi:10.46633/gjls.020105</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Shao M., Zhang, T. et al. Value of Hematological Parameters in Predicting Major Adverse Cardiovascular Events after PCI in Patients with Acute STEMI. Chinese General Practice. 2020;23(27): 3389-3395. doi: 10.12114/j.issn.1007-9572.2020.00.245</mixed-citation><mixed-citation xml:lang="en">Chen X., Shao M., Zhang, T. et al. Value of Hematological Parameters in Predicting Major Adverse Cardiovascular Events after PCI in Patients with Acute STEMI. Chinese General Practice. 2020;23(27): 3389-3395. doi: 10.12114/j.issn.1007-9572.2020.00.245</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Emrah A., Uğur A., Merve L. Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients with ST-Elevated Myocardial Infarction. Angiology. 2022;74(9). DOI:10.1177/00033197221121435</mixed-citation><mixed-citation xml:lang="en">Emrah A., Uğur A., Merve L. Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients with ST-Elevated Myocardial Infarction. Angiology. 2022;74(9). DOI:10.1177/00033197221121435</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rostami А., Tajlil А., Separham А. et al. Association between Neutrophil-to-Lymphocyte Ratio and the Systemic Inflammatory Immunologic Index and the Angiographic SYNTAX Score and the TIMI Flow Grade in Acute STEMI: A Cohort Study. J Tehran Heart Cent. 2021;16(4):147–155. doi: 10.18502/jthc.v16i4.8600</mixed-citation><mixed-citation xml:lang="en">Rostami А., Tajlil А., Separham А. et al. Association between Neutrophil-to-Lymphocyte Ratio and the Systemic Inflammatory Immunologic Index and the Angiographic SYNTAX Score and the TIMI Flow Grade in Acute STEMI: A Cohort Study. J Tehran Heart Cent. 2021;16(4):147–155. doi: 10.18502/jthc.v16i4.8600</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dolu А.К., Karayiğit О., Ozkan С. et al. Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction. Acta Cardiologica. 2023;78(1):72-79. doi:10.1080/00015385.2022.2035082</mixed-citation><mixed-citation xml:lang="en">Dolu А.К., Karayiğit О., Ozkan С. et al. Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction. Acta Cardiologica. 2023;78(1):72-79. doi:10.1080/00015385.2022.2035082</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Hu S, Liang C, Ling Y. The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention. BMC Cardiovascular Disorders. 2022;22:525. doi:10.1186/s12872-022-02989-9</mixed-citation><mixed-citation xml:lang="en">Wang J, Hu S, Liang C, Ling Y. The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention. BMC Cardiovascular Disorders. 2022;22:525. doi:10.1186/s12872-022-02989-9</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гельцер Б.И., Шахгельдян К.И., Домжалов И.Г. и др. Показатели клинического анализа крови и поражения коронарного русла в прогнозировании госпитальной летальности у больных острым инфарктом миокарда с подъемом сегмента ST после чрескожного коронарного вмешательства. Российский кардиологический журнал. 2024;29(2):5549. https://doi.org/10.15829/1560-4071-2024-5549.</mixed-citation><mixed-citation xml:lang="en">Geltser B.I., Shahgeldyan K.I., Domzhalov I.G. et al. Parameters of complete blood count and coronary lesions in predicting inhospital mortality in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention. Russian Journal of Cardiology. 2024;29(2):5549. (In Russ.) doi:10.15829/1560-4071-2024-5549.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Хубулава Г. Г., Козлов К. Л., Шишкевич А. Н. и др. Предикторы реперфузионного синдрома миокарда: современный взгляд на вопрос и актуальные проблемы. Часть 1: Реперфузионные аритмии, необратимое повреждение и оглушение миокарда (обзор литературы). Регионарное кровообращение и микроциркуляция. 2021;20(2):20–26. doi:10.24884/1682-6655-2021-20-2-20-26.</mixed-citation><mixed-citation xml:lang="en">Khubulava G.G., Kozlov K.L., Shishkevich A.N. et al. Predictors of myocardial reperfusion syndrome: a modern view of the issue and current problems. Part 1: Reperfusion arrhythmias, injury and stunning myocardium (review of literature). Regional blood circulation and microcirculation. 2021;20(2):20-26. (In Russ.) doi:10.24884/1682-6655-2021-20-2-20-26.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplangoray М., Toprak К., Deveci Е. et al. Could Pan‑Immune‑Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon? Cardiovascular Toxicology. 2024. 24:519–526.doi:10.1007/s12012-024-09855-4</mixed-citation><mixed-citation xml:lang="en">Kaplangoray М., Toprak К., Deveci Е. et al. Could Pan‑Immune‑Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon? Cardiovascular Toxicology. 2024. 24:519–526.doi:10.1007/s12012-024-09855-4</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Шварц В.А., Талибова С.М., Сокольская М.А. и др. Ассоциация новых биомаркеров системного воспаления с развитием атеросклероза и его выраженностью. Российский кардиологический журнал. 2024;29(8):6025. doi:10.15829/1560-4071-2024-6025.</mixed-citation><mixed-citation xml:lang="en">Shvarts V.A., Talibova S.M., Sokolskaya M.A. et al. Association of novel biomarkers of systemic inflammation with atherosclerosis and its severity. Russian Journal of Cardiology. 2024;29(8):6025. (In Russ.) doi:10.15829/1560-4071-2024-6025.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Савицкий, А.А., Руднов В.А. Клиническое значение эозинопении у хирургических пациентов с признаками системной воспалительной реакцией // Уральский медицинский журнал. 2015:7(130):132-141.</mixed-citation><mixed-citation xml:lang="en">Savitskiy A.A., Rudnov V.A. Clinical significance of eosinopenia in surgical patients with systemic inflammatory response syndrome. Ural Medical journal. 2015:7(130):132-141. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Konishi T., Funayama N., Yamamoto T. et al. Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. 2017;24(8): 827-840. doi:10.5551/jat.37937</mixed-citation><mixed-citation xml:lang="en">Konishi T., Funayama N., Yamamoto T. et al. Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. 2017;24(8): 827-840. doi:10.5551/jat.37937</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sicklinger F., Meyer I.S., Li X. et al. Basophils balance healing after myocardial infarction via IL-4/IL-13. J Clin Invest. 2021;131(13):e136778. doi:10.1172/JCI136778.</mixed-citation><mixed-citation xml:lang="en">Sicklinger F., Meyer I.S., Li X. et al. Basophils balance healing after myocardial infarction via IL-4/IL-13. J Clin Invest. 2021;131(13):e136778. doi:10.1172/JCI136778.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon G.S., Choi S.H., Woo S.I. et al. Neutrophil-to-Lymphocyte Ratio at Emergency Room Predicts Mechanical Complications of ST-segment Elevation Myocardial Infarction. Journal of Korean Medical Science. 2021; 36(19): e131. doi:10.3346/jkms.2021.36.e131</mixed-citation><mixed-citation xml:lang="en">Yoon G.S., Choi S.H., Woo S.I. et al. Neutrophil-to-Lymphocyte Ratio at Emergency Room Predicts Mechanical Complications of ST-segment Elevation Myocardial Infarction. Journal of Korean Medical Science. 2021; 36(19): e131. doi:10.3346/jkms.2021.36.e131</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
